Ongoing research aims to clarify BPC-157s mechanism of reducing inflammation and promoting recovery
The condensed criteria are below for the full methodology, jump to our complete ranking criteria
Do not use GLP-1 treatments if: Warnings and Precautions: Pregnancy and Reproductive Health: GLP-1 medications may cause harm to a fetus and should not be used during pregnancy or when planning to become pregnant
Medication alternatives to Januvia (Sitagliptin) If your healthcare provider prefers to put you on another treatment, they may suggest another DPP-4 inhibitor or an anti-diabetic medication in another drug class
Retatrutide is often explored in multi-pathway signalling research Tirzepatide is commonly used in dual-pathway comparative studies As research continues, both compounds are expected to remain central to peptide-focused investigations
doi: 10.1093/brain/awad010 Summary Keywords autism, pathophysiology, bioenergetics, subtypes, biomarker, metabolomic, stratification, mitochondria Citation Smith AM, Donley ELR, Ney DM, Amaral DG, Burrier RE and Natowicz MR (2023) Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
